Sun, May 19, 2013, 9:51 PM EDT - U.S. Markets closed
Isis' partner, Genzyme, plans to commercialize Isis' lead product, KYNAMRO™, in Europe following EMA approval before the end of 2012.
Unfortunately for ISIS the EMA deadline has already passed and they didn't get it. It bodes well for AEGR though.